comprehensive -WSS

comprehensive

author：entertainment 2025-09-02 08:18:18 - browse：61

Pfizer and Moderna aren’t the only vaccine money-makers. Much of the revenue and profits from Covid-19 vaccines are flowing behind the scenes, going to the contract manufacturers and clinical-trial organizers that turn the shots from lab-bench theory to mass-produced reality.

Both AstraZeneca and Johnson & Johnson publicly committed to not profiting off their products during the pandemic — though AstraZeneca has reserved the right to declare the pandemic over on July 1, even if the World Health Organization has not. Pfizer and Moderna made no such pledge, with Pfizer expected to make $15 billion in vaccine-related revenue this year, while Moderna is forecasting $18.4 billion in vaccine sales.

Contractors hired to test and manufacture these vaccines have enjoyed a share of the profits without the same level of public scrutiny.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： How one medical school became remarkably diverse
Next article： Study says nonprofit hospitals fall short in charity care spending

focus

WSS

Custom gene therapy hints at new path for rare disease treatments

In early work, researchers turn to CRISPR to treat Alzheimer's

Covid vaccine financial winners and losers, from Pfizer to Novavax

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Custom gene therapy hints at new path for rare disease treatments

Washington mulls new rules to avert another Change Healthcare

focus

comprehensive

hotspot

Drug repurposing or repositioning? The language matters

AI can’t replace a physician’s gut feeling

United colonoscopy coverage change 'may cost lives,' doctors say

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Roche subsidiary Foundation Medicine opens new headquarters

In age of alternative facts, a scholarly course on calling out crap

Food as medicine: Medically tailored meals may get standardized

Alkermes shareholders re

Key House panel plots a new health care package

hotspot

As digital health tech proliferates, a new institute aims to cut through hype

Roche subsidiary Foundation Medicine opens new headquarters

How Medicaid coverage policies for immigrants impact new moms

Sanders adds drug shortage policies to pandemic preparedness bill

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Will generative AI in health care meet the fate of IBM's Dr. Watson?

explore

focus

explore

entertainment